LEXX

Lexaria Bioscience Corp. (LEXX) is an innovative biotechnology company based in Kelowna, Canada, focused on enhancing the health benefits of CBD through its proprietary DehydraTECH™ drug delivery technology. This patented platform optimizes the bioavailability of active pharmaceutical ingredients, positioning Lexaria as a key player in the dynamic cannabinoid industry. With a strong commitment to research and development, the company endeavors to expand cannabinoid applications across healthcare and wellness markets, effectively meeting diverse consumer health demands and capitalizing on growth opportunities within the evolving cannabis sector.